FDA Recalls EZ Breathe Atomizers Due to Choking Hazard
Nephron Pharmaceuticals is recalling EZ Breathe Atomizers because a component may dislodge, creating a choking hazard.
The agency’s classification
FDA (Devices): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this recall as Class I — a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. On that classification alone this is scored Severe; a score of Critical is reserved for recalls where a death or serious injury was reported. The agency gives the reason as: "Possible dislodgement of the "Plate A", if this instance occurs, it presents a potential choking hazard."
Plain-English summary
Nephron Pharmaceuticals Corp. is recalling 604 units of the EZ Breathe Atomizer, Model # EZ-100. This medical device is used for the delivery of liquid medications for respiratory usage.
The recall was initiated because the "Plate A" component of the atomizer may dislodge. If this occurs, it presents a potential choking hazard to the user.
The affected units were distributed nationwide in the United States, including DC and Puerto Rico, as well as in Guatemala, Poland, Panama, and the United Kingdom. Consumers should stop using the affected atomizers and contact the manufacturer for instructions on how to proceed.
The recalled product
- Product
- EZ Breathe Atomizer Model # EZ-100. For the delivery of liquid medications for respiratory usage.
- Manufacturer
- Nephron Pharmaceuticals Corp.
- Category
- Medical Device — Respiratory
- Hazard
- Affected units
- 604
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Model # EZ-100 Lots # R2029A
- R2029B
- R2039A
- R2042A
- R2045A
Distribution
Part of a larger recall action
This product is one of 3 recalled by Nephron Pharmaceuticals Corp. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Nephron Pharmaceuticals Corp.
See all →- HighNephron Recalls Sodium Chloride Inhalation Solution Due to Sterility Concerns
FDA (Devices) · 2016-07-06
- HighNephron Recalls Sodium Chloride Inhalation Solution Due to Sterility Concerns
FDA (Devices) · 2016-07-06
- ModerateNephron Recalls Asthmanefrin Racepinephrine Inhalation Solution Due to Discoloration
FDA (Drugs) · 2015-12-09
- ModerateNephron Recalls Asthmanefrin Inhalation Solution Due to Discoloration
FDA (Drugs) · 2015-12-09
- SevereNephron Recalls Ipratropium Bromide and Albuterol Sulfate Inhalation Solution
FDA (Drugs) · 2015-10-21
Same hazard · choking
See all →- CriticalAvengers Infinity Gauntlet Medals Recalled for Magnet Ingestion Risk
CPSC · 2026-10-08
- SevereGBYMIUY Recalls Magnetic Stick Figure Toys Due to Ingestion Hazard
CPSC · 2026-10-01
- High
- SevereABC Trading Recalls Squishy Toys Due to Water Bead Ingestion Risk
CPSC · 2026-10-01
- HighUnited Sugar Recalls Powdered Sugar Due to Potential Wheat Kernel Contamination
FDA (Food) · 2026-09-30
Similar recalls
- ModerateNephron Recalls Asthmanefrin Inhalation Solution Due to Discoloration
FDA (Drugs) · 2015-12-09
- HighDräger ID Circuit Basic Breathing Circuits Recalled for Detachment Risk
FDA (Devices) · 2021-03-17
- HighEpinephrine Injection Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-07-27
- CriticalResMed Astral 100/150 Ventilators Recalled Due to Electrolyte Leakage Risk
FDA (Devices) · 2026-08-05
- ModerateAerogen Nebulizer Power Adapter Recall Due to Broken Cover
FDA (Devices) · 2014-10-29
- HighDraeger VentStar Watertrap Breathing Circuits Recalled for Detachment Risk
FDA (Devices) · 2021-03-17